B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy

Kidney International

Volumn 73, Issue 10, 2008, Pages 1128-1136

  Buck, K S ^b   Smith, A C ^a   Molyneux, K ^a   El Barbary, H ^a   Feehally, J ^a   Barratt, J ^a,c  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b QUEEN MARGARET HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Gene expression; IgA; IgA nephropathy; Lymphocytes

Indexed keywords

BETA GALACTOSYLTRANSFERASE; CHAPERONE; GALACTOSE; GALACTOSYLTRANSFERASE; GLYCAN; MUCIN; N ACETYLGALACTOSAMINYLTRANSFERASE; URIDINE DIPHOSPHATE N ACETYL ALPHA DEXTRO GALACTOSAMINE:POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE 2;

ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SYNTHESIS;

EID: 42949166703     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002748     Document Type: Article

References (33)

1. Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy. Semin Nephrol 2004; 24: 197–217.
2. Kerr MA. The structure and function of human IgA. Biochem J 1990; 271: 285–296.
3. D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2. J Biol Chem 2003; 278: 5613–5621.
4. Ju T, Brewer K, D’Souza A et al. Cloning and expression of human core 1 beta1,3-galactosyltransferase. J Biol Chem 2002; 277: 178–186.
5. Ju T, Cummings RD. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci USA 2002; 99: 16613–16618.
6. Andre PM, Le Pogamp P, Chevet D. Impairment of jacalin binding to serum IgA in IgA nephropathy. J Clin Lab Anal 1990; 4: 115–119.
7. Allen AC, Harper SJ, Feehally J. Galactosylation of N-and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995; 100: 470-474.
8. Hiki Y, Iwase H, Saitoh M et al. Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy. Nephron 1996; 72: 429–435.
9. Odani H, Hiki Y, Takahashi M et al. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. Biochem Biophys Res Commun 2000; 271: 268–274.
10. Tomana M, Matousovic K, Julian BA et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997; 52: 509–516.
11. Kokubo T, Hiki Y, Iwase H et al. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 1998; 9: 2048–2054.
12. Hiki Y, Kokubo T, Iwase H et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 1999; 10: 760–769.
13. Amore A, Cirina P, Conti G et al. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 2001; 12: 1862–1871.
14. Allen AC, Bailey EM, Brenchley PE et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001; 60: 969–973.
15. Xu LX, Zhao MH. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int 2005; 68: 167–172.
16. Novak J, Moldoveanu Z, Renfrow MB et al. IgA nephropathy and Henoch–Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib Nephrol 2007; 157: 134–138.
17. Moldoveanu Z, Wyatt RJ, Lee JY et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 2007; 71: 1148–1154.
18. Allen AC, Bailey EM, Barratt J et al. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol 1999; 10: 1763–1771.
19. Berger EG. Tn syndrome. Biochim Biophys Acta 1999; 1455: 255–268.
20. Allen AC, Topham PS, Harper SJ et al. Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant 1997; 12: 701–706.
21. Qin W, Zhou Q, Yang LC et al. Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy. J Intern Med 2005; 258: 467–477.
22. Smith AC, de Wolff JF, Molyneux K et al. O-glycosylation of serum IgD in IgA nephropathy. J Am Soc Nephrol 2006; 17: 1192–1199.
23. Harper SJ, Pringle JH, Wicks AC et al. Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int 1994; 45: 836–844.
24. de Fijter JW, Eijgenraam JW, Braam CA et al. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 1996; 50: 952–961.
25. van den Wall Bake AW, Daha MR, Haaijman JJ et al. Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy. Kidney Int 1989; 35: 1400–1404.
26. Harper SJ, Allen AC, Pringle JH et al. Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol 1996; 49: 38–42.
27. Harper SJ, Allen AC, Bene MC et al. Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA. Clin Exp Immunol 1995; 101: 442–448.
28. Hiki Y, Odani H, Takahashi M et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59: 1077–1085.
29. Mestecky J, Tomana M, Crowley-Nowick PA et al. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 1993; 104: 172–182.
30. Inoue T, Sugiyama H, Kikumoto Y et al. Downregulation of the beta1,3-galactosyltransferase gene in tonsillar B lymphocytes and aberrant lectin binding to tonsillar IgA as a pathogenesis of IgA nephropathy. Contrib Nephrol 2007; 157: 120–124.
31. King MJ, Chan A, Roe R et al. Two different glycosyltransferase defects that result in GalNAca-O-peptide (Tn) expression. Glycobiology 1994; 4: 267–279.
32. Moore JS, Kulhavy R, Tomana M et al. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. Mol Immunol 2007; 44: 2598–2604.
33. Smith AC, Molyneux K, Feehally J et al. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol 2006; 17: 3520–3528.